These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group project. Colen RR; Vangel M; Wang J; Gutman DA; Hwang SN; Wintermark M; Jain R; Jilwan-Nicolas M; Chen JY; Raghavan P; Holder CA; Rubin D; Huang E; Kirby J; Freymann J; Jaffe CC; Flanders A; ; Zinn PO BMC Med Genomics; 2014 Jun; 7():30. PubMed ID: 24889866 [TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme. Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472 [TBL] [Abstract][Full Text] [Related]
12. A robust two-gene signature for glioblastoma survival prediction. Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992 [TBL] [Abstract][Full Text] [Related]
13. Machine-learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time. Liao X; Cai B; Tian B; Luo Y; Song W; Li Y J Cell Mol Med; 2019 Jun; 23(6):4375-4385. PubMed ID: 31001929 [TBL] [Abstract][Full Text] [Related]
14. MRI Features May Predict Molecular Features of Glioblastoma in Park CJ; Han K; Kim H; Ahn SS; Choi D; Park YW; Chang JH; Kim SH; Cha S; Lee SK AJNR Am J Neuroradiol; 2021 Mar; 42(3):448-456. PubMed ID: 33509914 [TBL] [Abstract][Full Text] [Related]
15. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway. Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987 [TBL] [Abstract][Full Text] [Related]
16. Radiogenomics-Based Risk Prediction of Glioblastoma Multiforme with Clinical Relevance. Qian X; Tan H; Liu X; Zhao W; Chan MD; Kim P; Zhou X Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927654 [TBL] [Abstract][Full Text] [Related]
17. Biologic Pathways Underlying Prognostic Radiomics Phenotypes from Paired MRI and RNA Sequencing in Glioblastoma. Sun Q; Chen Y; Liang C; Zhao Y; Lv X; Zou Y; Yan K; Zheng H; Liang D; Li ZC Radiology; 2021 Dec; 301(3):654-663. PubMed ID: 34519578 [TBL] [Abstract][Full Text] [Related]
18. Unveiling divergent treatment prognoses in IDHwt-GBM subtypes through multiomics clustering: a swift dual MRI-mRNA model for precise subtype prediction. Ji Q; Zheng Y; Zhou L; Chen F; Li W J Transl Med; 2024 Jun; 22(1):578. PubMed ID: 38890658 [TBL] [Abstract][Full Text] [Related]
19. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes. Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456 [TBL] [Abstract][Full Text] [Related]
20. Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma. Cui Y; Ren S; Tha KK; Wu J; Shirato H; Li R Eur Radiol; 2017 Sep; 27(9):3583-3592. PubMed ID: 28168370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]